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Transferring mouse ESCs to a media supplemented with Mek and Gsk3b inhibitors (2i) provokes marked
transcriptional and epigenetic changes, embodying a shift toward ground-state pluripotency. In this issue
of Cell Stem Cell, Kolodziejczyk et al. (2015) examine population structures of ESCs while Galonska et al.
(2015) unravel the mechanisms underlying regulatory network rewiring during 2i-mediated reprogramming.In engineered in vitro environments, self-
renewal of mouse ESCs (mESCs) is sup-
ported by Lif/Stat3 signaling (Niwa et al.,
1998). However, alternative culture con-
ditions profoundly alter key features of
mESCs. Cells propagated in serum reside
in a metastable state characterized by
fluctuating pluripotency factor levels and
a high rate of spontaneous differentia-
tion owing to active Mek-Erk signaling.
In contrast, 2i media utilizes Mek-Erk
inhibitors to shield cells from differentia-
tion signals while reinforcing cell viability
through inhibition of Gsk3b, thereby stim-
ulating the canonical Wnt pathway (Ying
et al., 2008). The resulting transcriptomic
and epigenomic changes coerce mESCs
to resemble a naive pluripotent state
found in the inner cell mass cells of early
embryos. Known hallmarks of naive plu-
ripotency include global DNA hypomethy-
lation, lack of bivalent chromatin, homog-
enous expression of pluripotency genes,
deep silencing of differentiation genes,
and ametabolic shift from oxidative phos-
phorylation to glycolysis (Marks et al.,
2012).
Our current understanding of these
distinct pluripotent states is limited to
‘‘bulk’’ analyses, which fail to capture
the complexity of cellular states within
mESCs. To overcome these limitations,
in this issue of Cell Stem Cell, Kolodziejc-
zyk et al. (2015) employ high-throughput
single-cell transcriptome profiling and
reveal new details of mESC organization.
By quantifying cell-to-cell variation in
gene expression, also known as tran-
scriptional noise, the authors discover
that global noise levels are not signifi-
cantly different between serum and
2i conditions. This finding is surprising
given that 2i mESC cultures exhibit
homogenous expression of pluripotency
factors in contrast to highly fluctuatinglevels in serum cultures (Marks et al.,
2012). Further investigation revealed that
although developmental and pluripotency
genes largely account for noise in serum
mESC data, cell-cycle genes are primarily
responsible for noise in 2i data. Noisy
expression may indicate the existence of
hidden subpopulations; thus, the authors
employed bioinformatics tools to analyze
cellular states under each media condi-
tion. They identified several distinct sub-
sets of cells that showed progressive de-
grees of differentiation in serum cultures,
in contrast to 2i cultures, which separate
into two subsets with differing expression
in G2/M genes. Importantly, while biolog-
ical replicates cluster according to culture
conditions, they did not identify a single
serum cell with a global gene expression
profile similar to that of a 2i cell, suggest-
ing that these cell populations have
distinct transcriptional identities.
In spite of the disparate effects of these
conditions, the two pluripotent states they
elicit are interconvertible. This phenome-
non enabled Galonska et al. (2015),
also in this issue of Cell Stem Cell, to
monitor the rewiring of regulatory net-
works during 2i-mediated reprogramming
(Figure 1). They found that the mESC
transcriptome undergoes a rapid trans-
formation, with the majority of genes
differentially expressed between the two
conditions exhibiting either upward or
downward trends as early as 24 hr after
the transfer to 2i media. This rapid tran-
scriptional reset is accompanied by dra-
matic changes in the binding patterns of
the core pluripotency factors Oct4,
Sox2, and Nanog (OSN). Nanog alone ac-
quires over 6,500 de novo sites while
losing almost 8,000 binding sites within
24 hr. Curiously, the expression levels of
OSN factors remain unaltered. The major-
ity of these early differential OSN bindingCell Stem Cell 1events occur within intergenic regions
that coincide with binding sites for p300,
a core component of the enhanceosome,
suggesting that a reorganization of the
enhancer activity landscape may be the
key event triggering the global reset of
transcriptional and epigenetic networks.
Next, the authors sought to test if either
the DNA hypomethylation or the loss
of Polycomb-mediated gene silencing
previously observed under 2i conditions
permits OSN to bind genomic loci inac-
cessible under serum conditions. How-
ever, both of these epigenetic hallmarks
appear to be reset much later in the con-
version process. Furthermore, depletion
of EED, an essential PRC2 component,
failed to disrupt the 2i transcriptome,
suggesting that Polycomb-mediated
silencing is dispensable for 2i-mediated
reprogramming.
Intriguingly, differentially bound OSN
regions are highly enriched for DNA mo-
tifs linked to transcriptional effectors of
Wnt and Erk signaling. For instance,
binding motifs for Egr1/2, the effectors
of the MAPK pathway that are highly ex-
pressed in serum, are found at OSN re-
gions that show increased binding in
serum, whereas OSN regions exhibiting
increased binding in 2i media are en-
riched for Tcf/Lef binding motifs, consis-
tent with the activation of Wnt signaling
under 2i conditions.
Integration of signaling pathways with
the OSN regulatory network is not entirely
unexpected. In mESCs maintained with
Lif and Bmp4, downstream pathway ef-
fectors Stat3 and Smad1 frequently co-
occupy OSN-bound active enhancers
(Chen et al., 2008). Crucially, the new find-
ings by Galonska et al. support a similar
role for a broader set of pathway-specific
factors and advance one step further to
suggest that pathway-specific factors7, October 1, 2015 ª2015 Elsevier Inc. 375
Figure 1. Putative Mechanism of 2i-Mediated Reprogramming
Upon transfer in 2i media, inhibition of the Mek-Erk pathway downregulates Egr1/2, while inhibition of
Gsk3b activates canonical Wnt signaling through stabilization of Tcf/b-Catenin nuclear complexes.
Differential expression of these factors leads to a rewiring of the enhancer network through differential
recruitment of the core pluripotency factors Oct4, Nanog, and Sox2. Subsequently, enhancer rewiring
leads to resetting of the transcriptome, epigenome, metabolome, and cell cycle.
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Previewsmay play a key role in the reset of the reg-
ulatory network by orchestrating the
redistribution of core pluripotency factors
across the genome.
How could pathway-specific factors
fulfill this role? A handful of ‘‘pioneer’’
transcription factors have been identified,
such as the pluripotency factors Oct4
and Sox2 and the lineage specification
factors Foxa2 and Ascl1, that access
and open inactive chromatin. This facili-
tates the subsequent recruitment of
other chromatin modifiers and transcrip-
tional activators and the assembly of
the Pol II transcriptional machinery (Soufi
et al., 2012). It will be important to deter-
mine whether Wnt and Mek-Erk pathway
effectors could function in a similar
manner. Furthermore, although the data
obtained by Galonska et al. suggest that
H3K4me3 and H3K27me3 chromatin
marks are dispensable for the initial re-
wiring of the regulatory network, it will376 Cell Stem Cell 17, October 1, 2015 ª201be necessary to examine other histone
modifications that could facilitate de
novo recruitment of pathway-specific ef-
fectors and/or OSN. To find suitable can-
didates, high-throughput mapping of an
extended set of histone modifications
(Tan et al., 2011) in mESCs under different
conditions would be required. Currently
available data appears to rule out the pos-
sibility that 2i-specific OSN binding re-
gions are shielded by DNA methylation
in serummESCs. Nevertheless, it remains
to be determined whether DNA demethy-
lation intermediates such as 5hmC, 5fC,
or 5caC (Ito et al., 2011) have a protective
function or, alternatively, can aid in the
recruitment of pathway effectors or OSN
to their cognate sites.
As the field makes strides toward a
better understanding of how pluripotency
is established and maintained, a number
of outstanding questions remain. Kolod-
ziejczyk et al. uncovered a few additional5 Elsevier Inc.factors that might be involved in pluripo-
tency maintenance under 2i conditions,
but these now await detailed functional
characterization. The functional link be-
tween the cell cycle and pluripotency
highlighted here and by recent studies in
human ESCs (Gonzales et al., 2015) war-
rants further investigation. Furthermore,
both studies point toward another unre-
solved question: how is the repression of
differentiation genes achieved in 2i when
Polycomb-mediated silencing is absent?
When juxtaposed, these new discov-
eries highlight an amazing ability of the
cells to quickly rewire gene regulatory net-
works in response to extracellular cues.
To this end, the mechanisms discussed
may not be limited to ESCs, but rather
may be utilized more broadly to regulate
changes in cellular fates during develop-
ment, differentiation, or disease.REFERENCES
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